Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, ...

Researchers evaluated whether hormonal biomarkers in women with relapsing-remitting MS varied significantly when accounting for menstrual phase or menopausal status.

Scientific studies have demonstrated that HRT can significantly improve life quality for those suffering from hormonal ...

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, ...

Breast cancer is one of the most common cancers affecting women globally. It starts when cells in the breast grow abnormally, often forming a lump or mass. Detecting breast cancer early is crucial for ...

As dementia and other neurodegenerative diseases become more common worldwide, researchers are searching urgently for ways to protect the brain as we age. One area attracting growing attention is ...

Add Yahoo as a preferred source to see more of our stories on Google. The Bayer Pharma AG logo is seen on April 03, 2025 in Berlin, Germany. (Maja Hitij via Getty Images) This story was originally ...

Two groundbreaking studies presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions in 2024 have revealed alarming connections between alcohol consumption and ...

All-cause mortality risk was not different between women who used menopausal hormone therapy and nonusers. In women who underwent bilateral oophorectomy between ages 45 and 54, those who took ...

Combining tirzepatide, the medication sold as Zepbound and Mounjaro, with menopause hormone therapy, can increase weight loss ...

The landscape of women’s hormonal health continues to evolve, with testosterone emerging as a key focus in challenging traditional medical paradigms and opening new pathways for understanding complex ...